Skip to main content
. 2016 Oct 15;6:138–142. doi: 10.1016/j.bbacli.2016.10.002

Table 4.

Univariate analyses of overall survival.

Parameters Overall survival
Median (± SD) (weeks)
p
Age patients
Young 58.3 (13.1) 0.008
Older 21.8 (6.6)



Gender
Male 49.9 (12.6) 0.21
Female 29.0 (7.5)



PS
Good 53.6 (10.9) 0.002
Worse 15.6 (3.6)



Weight loss
Yes 36.7 (6.6) 0.34
No 74.5 (41.5)



Jaundice
Yes 41.6 (18.8) 0.46
No 41.9 (7.8)



Localization
Head 48.3 (11.8) 0.54
Corpus-tail 34.4 (10.4)



pT size
Small 42.1 (9.4) 0.37
Large 36.4 (8.9)



Metastasis
Yes 26.5 (5.9) 0.008
No 76.7 (20.3)



Liver metastasis
Yes 30.0 (6.8) 0.02
No 9.5 (4.6)



ESR
High 34.3 (7.7) 0.24
Normal 43.9 (12.0)



Hb
Low 41.1 (11.5) 0.66
Normal 32.1 (7.0)



WBC
High 38.2 (12.2) 0.67
Normal 34.5 (7.2)



PLT
Low 27.5 (9.0) 0.59
Normal 37.2 (7.1)



Albumin
Low 30.9 (8.8) 0.79
Normal 32.8 (8.7)



LDH
High 24.5 (12.2) 0.06
Normal 38.3 (6.8)



CEA
High 30.1 (9.4) 0.66
Normal 36.8 (7.7)



CA 19.9
High 32.5 (6.0) 0.63
Normal 40.8 (16.0)



Response to CTx
Yes 48.1 (11.4) 0.03
No 23.1 (8.9)



Omentin
< Median 41.3 (8.8) 0.54
> Median 42.1 (14.6)

p ≤ 0.05.